Literature DB >> 10213270

Induction of iNOS in a rat model of acute colitis.

E Kankuri1, M Z Asmawi, R Korpela, H Vapaatalo, E Moilanen.   

Abstract

Induction of colitis by 2,4,6-Trinitrobenzenesulphonic acid (TNB) in the rat is a widely used experimental model of inflammatory bowel disease. Action of TNB as a hapten, induces colitis involving infiltration of colonic mucosa by neutrophils and macrophages and increased production of inflammatory mediators. The aim of the present study was to measure nitric oxide synthase (NOS) activity and characterize relations between inducible NOS (iNOS) activity and other signs of inflammation in TNB-induced colitis. A profound and sustained increase in the activity of iNOS was found in the colon. The activity of NOS in the spleen was also increased, but remained at low levels as compared to those in colon. No increases in plasma nitrite + nitrate concentrations were found suggesting local rather than systemic induction of iNOS. The increase in iNOS activity in the colon was preceded by macroscopic inflammatory lesions, like hyperemia, ulcerations and edema formation as well as neutrophil accumulation in the gastric mucosa and increased circulating concentrations of PGE2 metabolite (PGEM). Concentrations of PGEM in the plasma and myeloperoxidase activity (MPO; marker of neutrophil infiltration) in the gut declined in 48h whereas increased iNOS activity and the macroscopic inflammatory lesions remained over the 72h follow-up period. The results demonstrate increased local iNOS activity in TNB-Induced colitis mimicking the situation in human inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213270     DOI: 10.1023/a:1020241028723

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  44 in total

1.  Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.

Authors:  S J McKenzie; M S Baker; G D Buffinton; W F Doe
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats.

Authors:  H G Seo; I Takata; M Nakamura; H Tatsumi; K Suzuki; J Fujii; N Taniguchi
Journal:  Arch Biochem Biophys       Date:  1995-12-01       Impact factor: 4.013

3.  Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.

Authors:  H Kimura; S Miura; T Shigematsu; N Ohkubo; Y Tsuzuki; I Kurose; H Higuchi; Y Akiba; R Hokari; M Hirokawa; H Serizawa; H Ishii
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

4.  Enhanced systemic nitric oxide production in inflammatory bowel disease.

Authors:  D D Tran; J J Visser; M O Pool; M A Cuesta; K Hoekman; A S Peña; S G Meuwissen
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

5.  Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone.

Authors:  T B McCall; R M Palmer; S Moncada
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

6.  Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.

Authors:  M Ferretti; P Gionchetti; F Rizzello; A Venturi; P Stella; F Corti; J Mizrahi; M Miglioli; M Campieri
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

7.  Distribution of inducible nitric oxide synthase in ulcerative colitis.

Authors:  I Ikeda; T Kasajima; S Ishiyama; T Shimojo; Y Takeo; T Nishikawa; S Kameoka; M Hiroe; A Mitsunaga
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

8.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

9.  Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

Authors:  D Salvemini; M G Currie; V Mollace
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.

Authors:  O Kosonen; H Kankaanranta; U Malo-Ranta; A Ristimäki; E Moilanen
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

View more
  11 in total

1.  Tempol protects the gallbladder against ischemia/reperfusion.

Authors:  Pedro J Gomez-Pinilla; Pedro J Camello; Jesus A F Tresguerres; María José Pozo
Journal:  J Physiol Biochem       Date:  2010-06-23       Impact factor: 4.158

2.  Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.

Authors:  E Kankuri; K Vaali; R Korpela; I Paakkari; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

3.  Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice.

Authors:  Jia-Le Song; Jung-Ho Choi; Jae-Hoon Seo; Yaung-Iee Lim; Kun-Young Park
Journal:  J Med Food       Date:  2014-09       Impact factor: 2.786

4.  Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation.

Authors:  Qingjie Li; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

Review 5.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

6.  Assessment of cell cycle phase-specific effects of zerumbone on mitotically synchronous surface cultures of Physarum polycephalum.

Authors:  Iyyappan Rajan; Remitha Rabindran; N Nithya; T Lakshmipriya; P R Jayasree; P R M Kumar
Journal:  Protoplasma       Date:  2014-01-15       Impact factor: 3.356

7.  Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis.

Authors:  Wei-Guo Dong; Qiao Mei; Jie-Ping Yu; Jian-Ming Xu; Li Xiang; Yu Xu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

8.  Melatonin improves experimental colitis with sleep deprivation.

Authors:  Young-Sook Park; Sook-Hee Chung; Seong-Kyu Lee; Ja-Hyun Kim; Jun-Bong Kim; Tae-Kyun Kim; Dong-Shin Kim; Haing-Woon Baik
Journal:  Int J Mol Med       Date:  2015-01-27       Impact factor: 4.101

9.  Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse.

Authors:  Kyu-Hyun Han; Jong-Min Park; Migyeong Jeong; Young-Min Han; Eun-Jin Go; Juyeon Park; Hocheol Kim; Jae Gab Han; Oran Kwon; Ki Baik Hahm
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

10.  Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures.

Authors:  Crystal Y Q Du; Roy C Y Choi; Tina T X Dong; David T W Lau; Karl W K Tsim
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.